共 15 条
Anti-transglutaminase, antigladin and ultra purified anti-gladin antibodies in patients with a diagnosis of rheumatoid arthritis
被引:4
作者:
Dionisio Castillo-Ortiz, Jose
[1
]
Duran-Barragan, Sergio
[2
]
Sanchez-Ortiz, Adriana
[1
]
Ramos-Remus, Cesar
[2
,3
]
机构:
[1] UMAE, Hosp Especialidades, Ctr Med Nacl Occidente, Inst Mexicano Seguro Social, Guadalajara, Mexico
[2] Unidad Invest Enfermedades Cron Degenerat, Guadalajara, Mexico
[3] Hosp Gen Reg 45, Inst Mexicano Seguro Social, Guadalajara, Mexico
来源:
REUMATOLOGIA CLINICA
|
2011年
/
7卷
/
01期
关键词:
Rheumatoid arthritis;
Celiac disease;
Anti-tissue transglutaminase;
Anti-gliadin and ultra purified anti-gliadin antibodies;
D O I:
10.1016/j.reuma.2010.03.006
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Celiac disease (CD) is an enteric disease caused by dietary gluten in individuals with genetic predisposition. One of the clinical manifestations of CD is the peripheral arthritis that may simulate RA. Objective: To determine the frequency of anti-gliadin (aGL), anti-tissue transglutaminase (aTGT) and ultra purified anti-gliadin (AGLU) antibodies in patients with RA. Methods: Cross-sectional study. We included consecutive patients diagnosed as RA (ACR). Demographic and clinical data was registered by direct interview and serum levels of aGL, aTGT y aGLU were detrmined using ELISA. Results: Eighty-five RA patients were included; 87% were women. Mean age was 44+/-12 years, mean disease duration 12 +/-9 years. aGL IgG antibodies were positive in 16 patients, IgA aGL antibodies in 29 patients, aGLU in 14 patients and only one patient had aTGT. Conclusions: It is possible that CD may be the correct diagnosis in a patient with polyarthritis, even if the patient meets the ACR criteria for RA. In other words, CD should be considered among the differential diagnoses in a patient with poly-arthritis. (C) 2010 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:27 / 29
页数:3
相关论文